Food and Beverage
Search documents
Shareholders that lost money on Reckitt Benckiser Group plc (RBGLY) should contact Levi & Korsinsky about pending Class Action - RBGLY
Prnewswire· 2025-07-25 12:45
NEW YORK, July 25, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Reckitt Benckiser Group plc ("Reckitt Benckiser Group plc" or the "Company") (OTCQX: RBGLY) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Reckitt Benckiser Group plc investors who were adversely affected by alleged securities fraud between January 13, 2021 and July 28, 2024. Follow the link below to get more information and be contacted by a member of our team:https:/ ...
中国股票策略:2025 年第二季度公募基金、南向资金与 “国家队” 动向概览-China Equity Strategy Overview of MF, southbound flow & national teammovements in Q225
2025-07-25 07:15
Summary of Key Points from the Conference Call Industry Overview - The report focuses on the mutual fund (MF) sector in China, particularly analyzing the southbound flow of investments and movements of the "national team" in Q225 [2][4]. Core Insights and Arguments 1. **Sector Position Changes**: In Q225, mutual funds increased their positions in banks, telecom, and non-bank financials by 1.6 percentage points each, and 0.8 percentage points in non-bank financials. Conversely, positions in food & beverage and auto sectors were cut by 2.1 percentage points and 0.9 percentage points respectively [2][3]. 2. **Southbound Net Inflows**: Southbound net inflows reached RMB 273.9 billion, marking a 25% year-over-year increase. The financial sector saw the largest inflows, followed by consumer discretionary and healthcare sectors [4][52]. 3. **National Team's ETF Purchases**: The "national team" is estimated to have added over RMB 200 billion in A-share ETFs in Q225, with 65% allocated to CSI 300 Index ETFs. This action is seen as a measure to stabilize the capital market [5][15]. 4. **New MF Issuance Trends**: New issuance of actively managed mutual funds totaled 59.9 billion units in Q225, a 128% increase year-over-year, but a 73% decline from the peak in 2020-21. The performance of these funds is expected to improve with better market conditions [3][4]. 5. **Consumer Sector Dynamics**: The report highlights a shift in investor preference towards "new consumption" and innovative drugs, indicating a potential growth area for mutual funds [4][5]. Additional Important Insights 1. **Geopolitical Uncertainty**: Elevated geopolitical risks have led to a preference for defensive sectors, including national defense, which ranked fourth in MF position increases [2][4]. 2. **A/H Premium Trends**: The A/H premium has decreased significantly due to liquidity differences between A-shares and H-shares, suggesting a potential medium-term low for this premium [4][5]. 3. **Performance Evaluation Mechanism**: The new performance evaluation mechanism for mutual funds may reshape market dynamics, potentially leading to increased inflows as market performance improves [3][4]. 4. **Risks to Market Stability**: Risks facing China's equities include a hard landing in the property market and slow structural reforms, which could lead to market shocks if not adequately addressed [62]. This summary encapsulates the key points discussed in the conference call, providing insights into the mutual fund sector's performance, investor behavior, and market dynamics in China.
Class Action Filed Against Reckitt Benckiser Group plc (RBGLY) - August 4, 2025 Deadline to Join – Contact The Gross Law Firm
GlobeNewswire News Room· 2025-07-24 20:00
Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Reckitt Benckiser Group plc regarding a class action lawsuit related to misleading statements and omissions concerning the company's cow's milk-based formula, Enfamil, which allegedly increased the risk of NEC in preterm infants [1][3]. Group 1: Allegations and Class Period - The class period for the lawsuit is defined as January 13, 2021, to July 28, 2024 [3]. - Allegations include that Reckitt failed to disclose the increased risk of NEC for preterm infants consuming Enfamil, the impact on sales, and the exposure to legal claims, leading to materially false and misleading statements about the company's business and prospects [3]. Group 2: Shareholder Actions - Shareholders are encouraged to register for the class action by the deadline of August 4, 2025, to potentially become lead plaintiffs [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's status [4]. Group 3: Law Firm's Mission - The Gross Law Firm aims to protect investors' rights and ensure companies adhere to responsible business practices, seeking recovery for losses incurred due to misleading statements or omissions [5].
Analysts Estimate Kellanova (K) to Report a Decline in Earnings: What to Look Out for
ZACKS· 2025-07-24 15:01
Core Viewpoint - The market anticipates Kellanova (K) will report a year-over-year decline in earnings due to lower revenues for the quarter ended June 2025, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - Kellanova is expected to post quarterly earnings of $0.99 per share, reflecting a year-over-year decrease of 2% [3]. - Revenues are projected to be $3.18 billion, down 0.4% from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 1.33% lower in the last 30 days, indicating a reassessment by analysts [4]. - The Most Accurate Estimate for Kellanova is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -5.19% [12]. Earnings Surprise Prediction - A positive Earnings ESP is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [10]. - Kellanova currently holds a Zacks Rank of 4, making it challenging to predict an earnings beat [12]. Historical Performance - In the last reported quarter, Kellanova was expected to earn $0.98 per share but only achieved $0.90, resulting in a surprise of -8.16% [13]. - Over the past four quarters, Kellanova has beaten consensus EPS estimates three times [14]. Conclusion - Kellanova does not appear to be a compelling candidate for an earnings beat, and investors should consider other factors when making decisions regarding the stock ahead of its earnings release [17].
Ahead of Mondelez (MDLZ) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
ZACKS· 2025-07-24 14:16
Core Viewpoint - Analysts expect Mondelez (MDLZ) to report quarterly earnings of $0.68 per share, reflecting a year-over-year decline of 20.9%, with revenues projected at $8.88 billion, an increase of 6.4% from the previous year [1] Earnings Projections - There has been a downward revision of 0.2% in the consensus EPS estimate over the last 30 days, indicating a collective reassessment by analysts [1][2] Revenue Estimates by Geography - North America revenue is estimated at $2.59 billion, a decrease of 2.3% year-over-year [4] - Europe revenue is projected at $3.38 billion, an increase of 17.6% year-over-year [4] - AMEA revenue is expected to reach $1.71 billion, reflecting a year-over-year increase of 7.6% [4] - Latin America revenue is forecasted at $1.19 billion, indicating a decline of 3.5% year-over-year [5] Operating Income Estimates - Non-GAAP Operating Income for AMEA is estimated at $238.28 million, down from $292.00 million year-over-year [5] - Non-GAAP Operating Income for Europe is projected at $447.35 million, compared to $558.00 million from the previous year [5] - Non-GAAP Operating Income for North America is expected to be $491.50 million, down from $579.00 million year-over-year [6] - Non-GAAP Operating Income for Latin America is forecasted at $129.84 million, a decrease from $164.00 million year-over-year [6] Stock Performance - Mondelez shares have returned +4.3% over the past month, compared to a +5.7% change in the Zacks S&P 500 composite [6]
The Gross Law Firm Reminds Reckitt Benckiser Group plc Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 4, 2025 - RBGLY
Prnewswire· 2025-07-24 12:45
Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Reckitt Benckiser Group plc regarding a class action lawsuit alleging that the company made materially false and misleading statements about its cow's milk-based formula, Enfamil, which is linked to increased risks for preterm infants [1][2]. Group 1: Allegations and Class Period - The class period for the allegations is from January 13, 2021, to July 28, 2024 [1]. - The allegations include that Reckitt failed to disclose the increased risk of necrotizing enterocolitis (NEC) for preterm infants consuming Enfamil, which could impact sales and expose the company to legal claims [1]. Group 2: Next Steps for Shareholders - Shareholders are encouraged to register for the class action by August 4, 2025, to potentially be appointed as lead plaintiffs [2]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the status of the case [2]. Group 3: Firm's Mission - The Gross Law Firm aims to protect investors' rights against deceit and illegal business practices, ensuring companies adhere to responsible business practices [3].
BRBR STOCK NEWS: BellRing Brands, Inc. (NYSE:BRBR) is Facing a Securities Fraud Investigation – Investors with Losses are Notified to Contact BFA Law
GlobeNewswire News Room· 2025-07-24 12:07
NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into BellRing Brands, Inc. (NYSE: BRBR) for potential violations of the federal securities laws. If you invested in BellRing, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/bellring-brands-inc-class-action-lawsuit. Why is BellRing being Investigated? BellRing operates in the convenient nutrition category. The Company’s pr ...
Nestle flags further potential price hikes as tariffs, commodities weigh on margins
CNBC· 2025-07-24 09:58
Core Viewpoint - Nestle is facing rising commodity prices, particularly for coffee and cocoa, which may lead to further price increases for its products in the second half of the year [1][3]. Group 1: Pricing Actions and Sales Performance - CEO Laurent Freixe indicated that while the company has already implemented broad price hikes in the first half of the year, additional pricing actions may be necessary [2][5]. - Nestle reported a 2.9% organic sales growth in the first half of the year, slightly exceeding analysts' expectations of 2.8%, driven by a 2.7% increase in prices [3][4]. - Total reported sales for the period declined by 1.8% to 44.2 billion Swiss francs ($55.7 billion), which was slightly below analyst expectations of 44.6 billion Swiss francs [4]. Group 2: Financial Outlook and Challenges - CFO Anna Manz noted that the company faced challenges from currency fluctuations and minimal early impacts from U.S. tariffs in the first half, but expects these headwinds to worsen in the second half [5]. - The company anticipates that second half margins will be significantly lower than in the first half, as price increases will not fully offset rising input costs, tariffs, and foreign exchange impacts [5]. - Despite these challenges, Nestle maintained its guidance for organic sales growth to improve in 2025 compared to 2024, aiming for an underlying trading operating profit margin of 16% or above [5].
Rising Cash Flows Make These 4 Stocks Worth Choosing Now
ZACKS· 2025-07-23 15:36
Core Insights - The current second-quarter reporting cycle favors stocks with top-line growth and increasing profit numbers, with a focus on companies' efficiency in generating cash flows as a more rewarding investment strategy [1][2] Group 1: Importance of Cash Flow - A profit-making company can still face bankruptcy if it lacks cash flow management, highlighting the necessity of a solid cash position for flexibility and growth [2][3] - Positive cash flow indicates an increase in liquid assets, enabling a company to meet obligations, reinvest, and return wealth to shareholders, while negative cash flow suggests declining liquidity [4] - Increasing cash flow is essential for future growth, reflecting management's efficiency and reducing reliance on external financing [5] Group 2: Screening Parameters for Stocks - Stocks were screened for those with cash flow in the latest quarter at least equal to the 5-year average cash flow per share, indicating a positive trend [6] - Additional criteria included Zacks Rank 1, average broker rating of 1, current price above $5, and a VGM Score of B or better [7] Group 3: Featured Stocks - Catalyst Pharmaceuticals (CPRX) focuses on therapies for rare diseases, with a revised 2025 earnings estimate of $2.25 per share, reflecting a positive outlook [8] - SunOpta (STKL) provides supply-chain solutions in the food industry, with a 2025 EPS estimate of 18 cents, a 63.6% increase from the previous year [9] - Gambling.com (GAMB) offers marketing services for the online gambling industry, with a revised 2025 earnings estimate of $1.07 per share [10] - Orion Group (ORN) operates in construction services, with a revised 2025 earnings estimate of 17 cents per share [11]
Oatly Group (OTLY) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
ZACKS· 2025-07-23 14:30
Core Insights - Oatly Group AB reported revenue of $208.35 million for the quarter ended June 2025, reflecting a 3% increase year-over-year, but fell short of the Zacks Consensus Estimate by 0.54% [1] - The company's EPS was -$1.86, a decline from -$1.00 in the same quarter last year, resulting in an EPS surprise of -173.53% compared to the consensus estimate of -$0.68 [1] Revenue Breakdown - Revenue from Europe & International was $118.19 million, exceeding the two-analyst average estimate of $112.98 million [4] - Revenue from Greater China was $26.98 million, below the estimated $31.9 million by two analysts [4] - Revenue from North America was $63.19 million, slightly below the average estimate of $64.6 million from two analysts [4] Stock Performance - Oatly Group's shares have returned +19.2% over the past month, outperforming the Zacks S&P 500 composite's +5.9% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]